Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed COO
|
|
Invivyd, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/27/2023 |
3
| Cotter Sara (Director) has filed a Form 3 on Invivyd, Inc. |
| 03/28/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/06/2022 |
3
| Schmidt Peter (Chief Medical Officer) has filed a Form 3 on Invivyd, Inc. |
| 10/24/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/13/2022 |
3
| DRISCOLL FREDERICK W (Interim CFO) has filed a Form 3 on Invivyd, Inc. |
| 06/24/2022 |
3
| Berry Tamsin (Director) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 04/01/2022 |
3
| Elia Marc (SEE REMARKS) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 03/30/2022 |
3
| MEANWELL CLIVE (See Explanation of Responses.) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 03/30/2022 |
3
| Cox Christopher T (See Explanation of Responses) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 03/30/2022 |
3
| Polaris Venture Partners V, L.P. (See Remarks) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 11/22/2021 |
3
| Miller Redonda (Director) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 11/22/2021 |
3
| MARRAM ELLEN R (Director) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 11/02/2021 |
3
| Andersen Jill (Chief Legal Officer, Secretary) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 08/05/2021 |
3
| Mayer Howard (Director) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 08/05/2021 |
3
| Heyman Tomas J. (Director) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 08/05/2021 |
3
| Hershberger Elham (Chief Development Officer) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 08/05/2021 |
3
| Hering David (COO) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 08/05/2021 |
3
| Henderson Jane (CFO) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 08/05/2021 |
3
| Gerngross Tillman U. (CEO) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 08/05/2021 |
3
| Dabora Rebecca (Chief Technology Officer) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 08/05/2021 |
3
| Connolly Lynn (Chief Medical Officer) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 08/05/2021 |
3
| Adimab, LLC (10% Owner) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 08/05/2021 |
3
| Redmile Group, LLC (10% Owner) has filed a Form 3 on Adagio Therapeutics, Inc. |
|
|